US HB8139 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on September 1 2020 - 25% progression, died in committee
Action: 2020-09-01 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

SUPPLIES Act of 2020 Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020

Sponsors


History

DateChamberAction
2020-09-01HouseReferred to the House Committee on Energy and Commerce.
2020-09-01HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback